With Morrow almost Swedish, we raise our TP

Huge improvements priced in

Gjensidige Forskring ASA: 1 director

A director at Gjensidige Forskring ASA bought 1,000 shares at 236.000NOK and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

Gjensidige Forsikring (Hold, TP: NOK235.00) - Profitable growth ahead

On the back of repricing measures, mild winter weather, and a solid investment result, Gjensidige reported Q1 PTP of NOK1,719m, up ~60% YOY. Although we expect continued solid growth momentum on further price hikes of upwards of 19.5% in Private, the profitability focus is leading to some churn among Commercial clients. In sum, we have cut our 2026–2027e EPS by 1–2%, and reiterate our HOLD and NOK235 target price.

Financials beat just outweigh UW miss

Adj. PTP -13%/-17% vs IR and ABGSCe (higher large losses). Even more repricing could make consensus estimates unchanged. Stock valuation high, hence stock down 1-4% from the UW miss

A setback for AUM and returns

Heads-up for Q1 report, April 29

Norwegian banks Q1: priced for higher rates

Priced according to higher-for-longer scenario

Attractive yield but fundamentals well priced in

Need further details on bullish ROE guidance

A safer place to be

Nordic non-life Q1e: Should manage the turmoil

Positive R/R into report

Solid growth momentum into 2025e

Helped by benign weather with few storms, we expect solid underwriting across the Nordic P&C sector for Q1, with underlying performance further supported by earned repricing momentum and abating claims inflation. The sector is trading at an attractive average 2026e P/E of c15.2x and we see solid capital distribution prospects. We reiterate our recommendations on all our covered sector names and highlight Tryg as our top pick.

Non-life: Competition authority consider to look at the competition

The DCCA is out with report describing inefficient comp. Could be a drag for Tryg and ALMB despite the industry objections. ALMB drop looks attractive, but it could drag on for two more years.

Stockholm responds positively

Receive Swedish bank licence today from th SFSA. Plan to list at Nasdaq Stockholm, and operate from Jan 2026. Open for more efficient equity use; Swedish SOTP NOK 17-20/share

Sparebanken 1 SMN: 3 directors

Three Directors at Sparebanken 1 SMN bought 7,254 shares at between 181.260NOK and 182.310NOK. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

Heder Bank to offer mortgages at 4.99%

Storebrand (Buy, TP: NOK149.00) - Strong start to the year

Fuelled by strong AUM growth within Savings, and the effects of several rounds of insurance repricing, we forecast a Q1 PTP (before amortisation) of NOK1,166m, ~8% stronger YOY. With the new NOK1.5bn buyback underway, the company is offering an attractive payout yield of 6–7%. We believe the stock is attractively valued at a 2026e P/E of c10x, when adjusting for the excess capital to be distributed. We reiterate our BUY, and have raised our target price to NOK149 (140).